Biotech MapLight Jumps 8% in First US IPO Using Shutdown Fix

MapLight Therapeutics Inc. shares closed 8% higher in its trading debut after the biotechnology firm raised $258.9 million in an initial public offering and private placement.

Read more: https://www.bloomberg.com/news/articles/2025-10-27/biotech-maplight-jumps-23-in-first-us-ipo-using-shutdown-fix